Atai: Following the path that Spravato laid and moving beyond it
Investing Experts
00:00
Exploring Milestones in the BPL-03 Clinical Trial
This chapter outlines the key milestones in the phase 2b clinical trial for BPL-03, an intranasal formulation of 5-methoxy DMT. It highlights the trial structure, patient randomization, and the focus on measuring the treatment's efficacy and durability in addressing depression.
Transcript
Play full episode
